Opinion

Are we out of the woods yet?

The return to normal may just have to wait.

By: Date: December 14, 2020 Topic: European Macroeconomics & Governance

This opinion piece was originally published on Kathimerini.

Finally, the vaccine is here. Stock markets have reacted exuberantly and we can see the light at the end of the tunnel. The confinement and isolation that have weighed on old and young alike will come to an end and the economy can rebound back from its semi-comatose state. We can then all go back to business as usual.

Not so fast. Four in 10 doctors in Belgium, the country where I reside, are not themselves keen to take the COVID-19 vaccine. Similar results have been found also in the UK. It is likely that such concerns exist in other countries as well.

These doctors are not vaccine deniers. Their objection is that the vaccine, despite all the money, effort and best science dedicated to it, has simply not passed the test of time.

If you ask your friends, your colleagues, both older and younger, if they will get vaccinated against COVID-19, you will not get a clear answer. We may need 70% of the population to be vaccinated for herd immunity to be achieved.. Globally, that means that more than 5 billion people need to be vaccinated.

This is undoubtedly one of the biggest logistics challenges ever. And while the production and distribution of the vaccine is part of that, it is surprisingly not the only one. When doctors themselves, who are crucial for providing information and advice to the population, are sceptical in quite such high numbers, how can we expect to achieve a quick return to normal? More importantly, is the vaccine the solution we need it to be?

The more we hear the worries of others, the more it feels like we are witness to a tragedy of the commons: we need 70% of the population to be vaccinated, but I would rather be at the 30%, at least till we learn more about the vaccine.

While we were preparing for shortages and huge queues outside vaccination centres, we might end up seeing exactly the opposite: a surplus of vaccines and a shortage of demand.

As with other examples of the tragedy of the commons, government regulation is called on to protect the public good. However, when it comes to vaccines, particularly such new vaccines, there are ethical issues that prevent their compulsory administration.

There has been some discussion of soft enforcement through exclusion. In other words, only granting vaccinated groups access to certain events or spaces. But such softer measures run contrary to the 70% threshold. And they may not really be enforceable and might only achieve social unrest.

But what is then left? Communication and persuasion? No. We cannot ignore such a large minority. Either there is a point to the concerns of these four out of 10 doctors, in which case attempts to rush and persuade are synonymous with deceit, or these doctors do not have a point in which case why are they objecting at quite such high numbers?

What is greater, the premium for waiting or the cost of an unsafe vaccine? On second thoughts, we might not be in a tragedy of the commons, as it is not clear what serves the public good better. It goes without saying that it is science that provides the answers. But it is just not clear that it has already.

I fear that the return to normal may just have to wait.


Republishing and referencing

Bruegel considers itself a public good and takes no institutional standpoint.

Due to copyright agreements we ask that you kindly email request to republish opinions that have appeared in print to [email protected].

Read article More on this topic More by this author
 

Blog Post

A matter of life and death: governments must speed up vaccination

COVID-19 vaccination in Europe and the United States is moving too slowly and is failing to prevent avoidable death and economic disruption. More must be done to accelerate the campaign by targeting those most at risk.

By: Uri Dadush Topic: Global Economics & Governance Date: January 13, 2021
Read article More on this topic
 

Blog Post

Corporate insolvencies during COVID-19: keeping calm before the storm

Measures in major economies have protected companies from COVID-19 related insolvency, but have also protected weak firms. Nevertheless, support should remain as long as necessary, while cumbersome insolvency processes should be reformed for the long term.

By: Grégory Claeys, Mia Hoffmann and Guntram B. Wolff Topic: European Macroeconomics & Governance Date: January 7, 2021
Read article More on this topic More by this author
 

Blog Post

Has the European Union squandered its coronavirus vaccination opportunity?

The European Union’s purchases of frontrunner coronavirus vaccines are insufficient for the population’s near-term needs. The shortfall could have healthcare consequences and might delay economic reopening. Lessons should be learned for future pandemics.

By: J. Scott Marcus Topic: Innovation & Competition Policy Date: January 6, 2021
Read article More on this topic More by this author
 

Blog Post

When the future changes the past: fiscal indicator revisions

The 2020 pandemic economic shock has led to reassessment of fiscal policy measures in 2018 and earlier, because of faulty measurement of unobserved output gaps and structural balances. The current period of suspension of EU fiscal rules should be used to design a better fiscal framework.

By: Zsolt Darvas Topic: European Macroeconomics & Governance Date: January 5, 2021
Read article More on this topic More by this author
 

Opinion

Europe's disappointing investment deal with China

Why rush a deal that is so inherently complex?

By: Alicia García-Herrero Topic: Global Economics & Governance Date: January 4, 2021
Read article More on this topic More by this author
 

Blog Post

Happy New Year?

A recovery from the COVID-19 recession is underway though the suffering is far from over, especially for the most vulnerable. Inequality is both a consequence of the pandemic and a cause of its severity. Many countries need comprehensive policy change to address its worst effects.

By: Uri Dadush Topic: Global Economics & Governance Date: December 23, 2020
Read article Download PDF
 

Parliamentary Testimony

European Parliament

Monetary Policy in the times of corona: many unknown unknowns

Testimony to the European Parliament on monetary policy.

By: Maria Demertzis and Marta Domínguez-Jiménez Topic: European Macroeconomics & Governance, European Parliament, Testimonies Date: December 21, 2020
Read about event More on this topic
 

Past Event

Past Event

Health: Crisis governance for a vital global public good

Given the collapse in cooperation and of effective authority over health governance, what strategies should be pursued at international level, and by what means?

Speakers: Anne Bucher, Monica de Bolle, Amanda Glassman, Marisol Touraine and Jean Pisani-Ferry Topic: Global Economics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: December 17, 2020
Read about event Download PDF More on this topic
 

Past Event

Past Event

Europe and India: Comparing Approaches to Global Economic Challenges

Stakeholders from government, private sector, media and academia/institutions come together to review India-EU relations and point to a promising direction for the future.

Speakers: Yamini Aiyar, Suman Bery, Navroz K Dubash, Ignacio Garcia Bercero, Alicia García-Herrero, Rajat Kathuria, Gautam Mukhopadhaya, Ananth Padmanabhan, Georgios Petropoulos, André Sapir, Shyam Saran, Simone Tagliapietra and Guntram B. Wolff Topic: Global Economics & Governance Date: December 15, 2020
Read about event More on this topic
 

Past Event

Past Event

Innovative approaches to monitoring the risks and impact of COVID-19

What new innovative tools can we use to measure real-time economic and social risk?

Speakers: Zsolt Darvas, Jaime Garcia, Ben McWilliams, Nicola Villa and Georg Zachmann Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: December 8, 2020
Read article More on this topic More by this author
 

Blog Post

Can the gap in the Europe’s internal market for banking services be bridged?

The European Union has made significant progress to a more unified banking market but frictions remain between euro and non-euro countries. Without a coordinated approach to remaining issues in completing banking union, the gap could widen.

By: Thomas Wieser Topic: Finance & Financial Regulation Date: December 7, 2020
Read article More on this topic More by this author
 

Blog Post

COVID-19 has widened the income gap in Europe

Workers with low-educational levels suffered far worse than others in terms of COVID-19 related job losses during the first half of 2020 in the EU. Jobs for tertiary-educated workers even increased. Thus, the pandemic has increased income inequality, reinforcing the case for inclusive development.

By: Zsolt Darvas Topic: European Macroeconomics & Governance Date: December 3, 2020
Load more posts